Overview
How the Genomic Prostate Score (GPS) Works
The Genomic Prostate Score (GPS) test helps you assess your treatment choices once you have been diagnosed with localized prostate cancer. Just as every patient is different, so is every prostate cancer tumor. GPS uses genomics to give you and your doctor important risk information about how your individual tumor is likely to behave.
The test is performed on a small tissue sample already taken from your most recent biopsy. Once the sample arrives at the mdxhealth lab, the test measures the activity of a group of cancer-related genes in your tumor tissue. The activity of these genes provides important information about how your specific cancer might behave in the future. Your GPS result can help you and your doctor decide which treatment is right for you.
Am I a Candidate?
You may be a candidate for the GPS test if you have:
- A biopsy within the last 3 years
- Not yet started treatment
- Localized prostate cancer
What the Result Tells You
- How aggressive your cancer is
- Your level of risk for prostate cancer death within 10 years of surgery
- How likely your cancer is to spread (metastasize) within 10 years of surgery
- Your risk for adverse pathology